Vaccination and Immunisation summary table 2014-2015 (England)
NEW Programmes from 1 April 2014
Hepatitis B for new born babies at riskSFE
Run from/to
1 April 2014 to 31
March 2015
Newborn babies whose mother has Hepatitis
B are at increased risk of contracting
the disease. This programme is intended
to identify these newborn babies and
ensure they receive vaccination within
the first 3 months after birth and fourth
dose at the age of 1.
Incorporated into SFE
for providers of the
childhood immunisation
additional services.
Patient cohort/age range
In most cases it is expected hospitals
will provide the first vaccination and
obtain details of the mother’s practice
or intended GP practice and inform the
practice of the child’s
health/conditions and immunisations.
Due to the risk of babies being
registered elsewhere or details not
being provided by the hospital,
practices are required to identify
newborn babies registered with the
practice (by checking mother’s status,
not relying on hospital notice) who are
at risk of Hepatitis B and provide
appropriate vaccinations.
Patients will present for other childhood
flu vaccinations for at least one of the
doses and there are no contra-indications
to this.
Vaccine Supply
First dose provided by
birth of the baby. In
not, practices will be
the first dose and can
£7.64.
the hospital upon
the event that it is
required to administer
claim payment of
Second dose at 1 month of age
Third dose at 2 months (4 weeks between
doses)
Fourth dose after 12 months
Refer for, or do if appropriate in practice,
a blood test (which may a heel prick or
venepuncture test) which can be taken at the
point of the fourth dose.
Update the patient’s record with the results
of the blood test, notify patient and make
referral to paediatrics as necessary.
MenC vaccination (Freshers) - ES
Booster offered to freshers not
previously vaccinated with MenC since
reaching age 10.
Note: This is for first time students
only - if a student who is in their
second year self present at a practice
and is under 25, they would be covered
under the global sum payments.
1 April to 31 October
2014
To allow patients to be
vaccinated by home or
university town
practice.
Patients aged 17 to 25 at any time
during the financial year 14/15 who are
attending university (or higher
education) for the first time and selfpresent to the practice requesting
vaccination and have not been immunised
since age 10.
Enhanced service
specification outlines
the requirements
There will be no requirement for
practices identify these patients or
demand proof of a university offer.
This will NOT be centrally supplied.
Practices to procure directly and claim
reimbursement for vaccine and administration
fee.
Provided by central supply by PHE via the
ImmForm website
Payment dates
Monthly from July
2014
Payment for the
first dose after
the first dose if
hospital fails to
administer.
Payment for second
and third dose
after third dose.
Payment
£7.64
for each
of the 3
or 4 (if
first
dose not
done in
hospital
) doses
delivere
d
Separate payment
for fourth dose payment dependant
on completed blood
test updated on
patient record.
Payment monthly
from July 2014 paid per completed
delivery (1 dose).
£7.64
per dose
Those that present
to the practice
are likely to do
so in the summer
months after
acceptance at
University.
Practices may offer the immunisation
opportunistically to eligible patients.
Prospective students will be advised to
seek vaccination when they receive a
provisional or firm offer via UCAS.
Existing programmes continuing from 1
April 2014
MMR – SFE
The original MMR programme in 2013 was a
response to an outbreak and required
practices to identify patients aged 10-16
who were unvaccinated and invite them to
receive a MMR vaccine. This requirement
is now retired.
Payment for this was covered in the
Global Sum and continues to be the case
for any patients aged 10-16 who selfpresent or are identified on an
opportunistic basis.
Run from/to
Patient cohort/age range
Vaccine Supply
Payment dates
Payment
1 April 2014 to 31
March 2015
Patients aged 16 and over that have no
record of vaccination, who self-present
to the practice requesting vaccination.
Provided by central supply by PHE via the
ImmForm website
Monthly from July
2014
£7.64
per dose
Moved from an enhanced
service, to being
included in the SFE.
1 or 2
doses
may be
necessar
y
Item of service fee for
providers of the
vaccination and
immunisation additional
service.
1
Additionally patients over 16 who had no
record of vaccination, who self-present
to the practice requesting vaccination,
were to be vaccinated. This is to
continue.
Pertussis in pregnant women - temporary
ES
1 April 2014 to 31
March 2015
Since 1 October 2012, a temporary
programme of pertussis (whooping cough)
vaccinations for pregnant women has been
in place, while the JCVI evaluate the
cost and clinical effectiveness of the
programme.
Rotavirus - SFE
Enhanced service
specification outlines
the requirements.
Vaccination of pregnant women and for
new mothers who missed the opportunity
to be vaccinated while pregnant.
Provided by central supply by PHE via
ImmForm website
1 April 2014 to 31
March 2015.
Children aged between 6 weeks and 6
months (not over 24 weeks).
Existing programmes continuing from 1
August 2014
Seasonal Influenza for at-risk patients DES/ES
Service delivered
from/to
1 August 2014 to 31
March 2015
The seasonal influenza programme is
historically wider than the DES - as
identified in the Green Book including
pregnant women but excluding 2-4 year
olds.
The DES Directions will
not be updated to
include at-risk group
and pregnant women.
Instead, an enhanced
service specification
will reflect both the
DES and the other risk
groups as identified in
the Green Book.
the
Monthly from July
2014
£7.67
per dose
– for
each
pregnanc
y
Provided by central supply by PHE via the
ImmForm website.
Monthly from July
2014
£7.64
for
complete
d course
- two
doses
Patient cohort/age range
Vaccine Supply
Payment dates
Payment
The programme will mirror the at-risk
groups in the Green Book to include
pregnant women, but excluding 2-4 year
olds, as they are covered under the
childhood flu programme.
There is a change to how the vaccines for atrisk children are supplied. All children aged
2-17 should receive Fluenz, as it is
identified as the most clinically effective
vaccine.
Monthly from
October 2014
£7.64
per dose
Patients aged 6 -24 months in clinical
risk groups need inactivated vaccine,
which will be purchased and centrally
supplied by PHE.
For children aged 6 months to 17 years, the
vaccine will be provided from central supply
by PHE via the ImmForm website. The PA fee
will not be applicable for this age group.
2-17 year olds need Fluenz or
inactivated vaccine (where Fluenz is
contraindicated) which will be
purchased and centrally supplied by
PHE.
Excluding at-risk children, practices are
required to procure their own vaccine and
should ensure they have enough other vaccines
for contraindicated patients. Practices will
be reimbursed for the cost of the vaccine and
for an administration fee. Practices will
claim these fees in the normal way.
From 1 July 2013, the rotavirus vaccine
was introduced to the childhood
immunisation schedule (at 2 and 3
months).
NHS England has now agreed to commission
the flu immunisation for the wider risk
groups identified in the Green Book as
from 1 April 2014.
Practices are required to call/recall the
patient for vaccination.
18-64 years in clinical risk groups and
over 65s need inactivated vaccine and
practices must procure from
manufacturers themselves.
2
Childhood Seasonal Influenza - ES
The children’s flu programme was
introduced in September 2013; the
intended cohort is patients aged 2-17
which will be rolled out over the next
few years.
1 September 2014 to 31
March 2015
Enhanced service
specification outlines
the requirements.
There is extension to the current
enhanced service to include children
aged 4, so that the new cohort is
children aged 2-4.
There is an addition to this programme to
resolve a historic anomaly between the
enhanced service and the recommended
cohort as indicated within the Green
Book.
Monthly from
October 2014
£7.64
per dose
Monthly from
October 2014
£7.64
per dose
For children aged 6 months to 17 years, the
vaccine will be provided from central supply
by PHE via the ImmForm website.
As from 1 April 2014, the enhanced
service has been extended to include
children aged 4, so that the new cohort
is children aged 2-4.
Practices are required to call/recall the
patient for vaccination.
Pneumococcal - DES
There is a change to how the vaccines for atrisk children are supplied. All children aged
2 to 17 should receive Fluenz, as it is
identified as the most clinically effective
vaccine.
The PA fee will not be applicable for this
age group.
1 August 2014 to 31
March 2015
Patients who have achieved the age of
65 or who meet the at-risk criteria
identified in the Green Book.
The DES Directions
incorporating this
programme will come
into effect 1 April
2014.
Practices will be required to purchase
adequate number of vaccines to deliver the
programme.
Practices will be reimbursed for the cost of
the vaccine and for an administration fee.
Practices will claim these fees in the normal
way.
The requirement from 1 April 2014 will be
to offer vaccination to patients who have
achieved the age of 65 (during the
financial year 14/15) AND to patients are
identified as at clinical risk as
indicated in the Green Book,
Practices are required to call/recall the
patient for vaccination.
Shingles routine aged 70 - SFE
1 September 2014 to 31
August 2015
Patients who have achieved the age of
70 but not 71 on 1 September 2014
Provided by central supply by PHE via the
ImmForm website
Monthly
October 2014
Continuation of the existing programme to
identify patients eligible for Shingles
vaccination.
Vaccination of patients is on an
opportunistic basis and can be done
alongside the flu vaccination programme.
Shingles catch-up - ES
Continuation of the existing catch-up
programme which aims for patients aged
71-79 to be vaccinated – the programme is
phased in view of vaccine supply and
available funding. From 1 April 2014, the
age cohort has been extended to include
patients aged 78.
from
£7.64
Single
dose to
last
lifetime
1 September 2014 to 31
August 2015
From 1 April 2014 cohort extended to
include patients aged 78.
Enhanced service
specification outlines
the requirements.
Identify patients who have attained the
age of 78 and 79 but not 80 on 1
September 2014 and offer a shingles
vaccination.
Vaccination of patients is on an
opportunistic basis and can be done
alongside the flu vaccination programme.
3
Provided from central supply by PHE via the
ImmForm website
Monthly from
October 2014
£7.64
Single
dose to
last
lifetime